{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T16:33:03Z","timestamp":1789576383770,"version":"build-2803163510"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100024075","name":"Region of Southern Denmark","doi-asserted-by":"publisher","award":["20\/14277"],"award-info":[{"award-number":["20\/14277"]}],"id":[{"id":"10.13039\/501100024075","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004196","name":"Odense Universitetshospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006356","name":"Syddansk Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006356","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["88887.889772\/2023\\u201300"],"award-info":[{"award-number":["88887.889772\/2023\\u201300"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["88887.570391\/2020\\u201300"],"award-info":[{"award-number":["88887.570391\/2020\\u201300"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["88887.310463\/2018\\u201300"],"award-info":[{"award-number":["88887.310463\/2018\\u201300"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.biopha.2025.118668","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T01:38:20Z","timestamp":1761183500000},"page":"118668","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Transcriptomic profiling of organoids derived from malignant effusions uncovers lncRNA MEG3 and target genes potentially involved in platinum resistance in serous ovarian carcinoma"],"prefix":"10.1016","volume":"192","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2681-0987","authenticated-orcid":false,"given":"Naiade","family":"Calanca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0285-1162","authenticated-orcid":false,"given":"Claudia Aparecida","family":"Rainho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4856-8046","authenticated-orcid":false,"given":"Debora Kazumi","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3966-8764","authenticated-orcid":false,"given":"Luiza","family":"C\u00f4rtes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolando Andr\u00e9 Rios","family":"Villacis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6536-994X","authenticated-orcid":false,"given":"Daniela","family":"Bizinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hellen","family":"Kuasne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mads Malik","family":"Aagaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars Ulrik","family":"Fokdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina Dahl","family":"Steffensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0020-1537","authenticated-orcid":false,"given":"Lars Henrik","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia Regina","family":"Rogatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.118668_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2015.00149","article-title":"Harnessing pandemonium: the clinical implications of tumor heterogeneity in ovarian cancer","volume":"5","author":"Blagden","year":"2015","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biopha.2025.118668_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2021.102074","article-title":"Ovarian cancer survival by stage, histotype, and pre-diagnostic lifestyle factors, in the prospective UK million women study","volume":"76","author":"Gaitskell","year":"2022","journal-title":"Cancer Epidemiol."},{"key":"10.1016\/j.biopha.2025.118668_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20040952","article-title":"High-grade serous ovarian cancer: basic sciences, clinical and therapeutic standpoints","volume":"20","author":"Lisio","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118668_bib4","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/jamaoncol.2023.0197","article-title":"Advances in ovarian cancer care and unmet treatment needs for patients with platinum resistance","volume":"9","author":"Richardson","year":"2023","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.biopha.2025.118668_bib5","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1002\/cncr.34903","article-title":"The highs and lows of serous ovarian cancer","volume":"129","author":"Grisham","year":"2023","journal-title":"Cancer"},{"key":"10.1016\/j.biopha.2025.118668_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104001","article-title":"Multi-omics approaches for biomarker discovery in early ovarian cancer diagnosis","volume":"79","author":"Xiao","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.biopha.2025.118668_bib7","doi-asserted-by":"crossref","DOI":"10.1186\/s13148-018-0602-0","article-title":"Epigenetic therapy for ovarian cancer: promise and progress","volume":"11","author":"Moufarrij","year":"2019","journal-title":"Clin. Epigenet."},{"key":"10.1016\/j.biopha.2025.118668_bib8","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41580-022-00566-8","article-title":"Long non-coding RNAs: definitions, functions, challenges and recommendations","volume":"24","author":"Mattick","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2025.118668_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2019.01549","article-title":"Long Non-coding RNAs involved in resistance to chemotherapy in ovarian cancer","volume":"9","author":"Abildgaard","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biopha.2025.118668_bib10","first-page":"91","article-title":"Gene microarray analysis of lncRNA and mRNA expression profiles in patients with high-grade ovarian serous cancer","volume":"42","author":"Lou","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.biopha.2025.118668_bib11","first-page":"8363","article-title":"LncRNAs are novel biomarkers for differentiating between cisplatin-resistant and cisplatin-sensitive ovarian cancer","author":"Li","year":"2018","journal-title":"Oncol. Lett. 15"},{"key":"10.1016\/j.biopha.2025.118668_bib12","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.cell.2016.05.082","article-title":"Modeling development and disease with organoids","volume":"165","author":"Clevers","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2025.118668_bib13","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1056\/NEJMra1806175","article-title":"Organoids \u2014 preclinical models of human disease","volume":"380","author":"Li","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2025.118668_bib14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41416-020-0875-x","article-title":"The untapped potential of ascites in ovarian cancer research and treatment","volume":"123","author":"Ford","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2025.118668_bib15","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrc3432","article-title":"Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research","volume":"13","author":"Kipps","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2025.118668_bib16","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.arbres.2013.11.007","article-title":"Etiology of pleural effusions: analysis of more than 3,000 consecutive thoracenteses","volume":"50","author":"Porcel","year":"2014","journal-title":"Arch. Bronconeumol. Engl. Ed."},{"key":"10.1016\/j.biopha.2025.118668_bib17","first-page":"160","article-title":"Serum CA125 and ascites leptin level ratio predicts baseline clinical resistance to first-line platinum-based treatment and poor prognosis in patients with high grade serous ovarian cancer","volume":"9","author":"Matte","year":"2019","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.biopha.2025.118668_bib18","doi-asserted-by":"crossref","first-page":"4570","DOI":"10.18632\/oncotarget.27827","article-title":"Chemotherapy sensitivity testing on ovarian cancer cells isolated from malignant ascites","volume":"11","author":"den Ouden","year":"2020","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2025.118668_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15164128","article-title":"Development of a Patient-Derived 3D Immuno-Oncology platform to potentiate immunotherapy responses in Ascites-Derived circulating tumor cells","volume":"15","author":"Gerton","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.biopha.2025.118668_bib20","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12964-022-00991-4","article-title":"Single-cell and bulk RNA sequencing reveal ligands and receptors associated with worse overall survival in serous ovarian cancer","volume":"20","author":"Carvalho","year":"2022","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.biopha.2025.118668_bib21","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/s41591-019-0422-6","article-title":"An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity","volume":"25","author":"Kopper","year":"2019","journal-title":"Nat. Med"},{"key":"10.1016\/j.biopha.2025.118668_bib22","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.devcel.2023.04.012","article-title":"A platform for efficient establishment and drug-response profiling of high-grade serous ovarian cancer organoids","volume":"58","author":"Senkowski","year":"2023","journal-title":"Dev. Cell"},{"key":"10.1016\/j.biopha.2025.118668_bib23","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1093\/bioinformatics\/btw354","article-title":"MultiQC: summarize analysis results for multiple tools and samples in a single report","volume":"32","author":"Ewels","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.biopha.2025.118668_bib24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.biopha.2025.118668_bib25","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"Featurecounts: an efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.biopha.2025.118668_bib26","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/nprot.2009.97","article-title":"Mapping identifiers for the integration of genomic datasets with the R\/Bioconductor package biomart","volume":"4","author":"Durinck","year":"2009","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.biopha.2025.118668_bib27","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.biopha.2025.118668_bib28","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biopha.2025.118668_bib29","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkv1507","article-title":"TCGAbiolinks: an R\/Bioconductor package for integrative analysis of TCGA data","volume":"44","author":"Colaprico","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biopha.2025.118668_bib30","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","article-title":"Visualizing and interpreting cancer genomics data via the xena platform","volume":"38","author":"Goldman","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biopha.2025.118668_bib31","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.ygyno.2020.03.026","article-title":"Short-term organoid culture for drug sensitivity testing of high-grade serous carcinoma","volume":"157","author":"Chen","year":"2020","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.biopha.2025.118668_bib32","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","article-title":"The sva package for removing batch effects and other unwanted variation in high-throughput experiments","volume":"28","author":"Leek","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.biopha.2025.118668_bib33","doi-asserted-by":"crossref","first-page":"D564","DOI":"10.1093\/nar\/gkac989","article-title":"EpiFactors 2022: expansion and enhancement of a curated database of human epigenetic factors and complexes","volume":"51","author":"Marakulina","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.biopha.2025.118668_bib34","doi-asserted-by":"crossref","first-page":"W459","DOI":"10.1093\/nar\/gkab435","article-title":"ncFANs v2.0: an integrative platform for functional annotation of non-coding RNAs","volume":"49","author":"Zhang","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.biopha.2025.118668_bib35","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2164-14-651","article-title":"Computational prediction of associations between long non-coding RNAs and proteins","volume":"14","author":"Lu","year":"2013","journal-title":"BMC Genom."},{"key":"10.1016\/j.biopha.2025.118668_bib36","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.biosystems.2014.11.005","article-title":"CytoNCA: a cytoscape plugin for centrality analysis and evaluation of protein interaction networks","volume":"127","author":"Tang","year":"2015","journal-title":"BioSystems"},{"key":"10.1016\/j.biopha.2025.118668_bib37","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/nprot.2012.004","article-title":"Topological analysis and interactive visualization of biological networks and protein structures","volume":"7","author":"Doncheva","year":"2012","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.biopha.2025.118668_bib38","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.3390\/cancers14071664","article-title":"The long Non-Coding RNA SNHG12 as a mediator of carboplatin resistance in ovarian cancer via epigenetic mechanisms","volume":"14","author":"Abildgaard","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.biopha.2025.118668_bib39","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.biopha.2025.118668_bib40","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","article-title":"Complex heatmaps reveal patterns and correlations in multidimensional genomic data","volume":"32","author":"Gu","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.biopha.2025.118668_bib41","doi-asserted-by":"crossref","first-page":"5417","DOI":"10.1038\/s41467-023-41132-w","article-title":"Systematic transcriptional analysis of human cell lines for gene expression landscape and tumor representation","volume":"14","author":"Jin","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2025.118668_bib42","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1868-7083-5-3","article-title":"Pharmacokinetic and pharmacodynamic analysis of 5-aza-2\u2019-deoxycytidine (decitabine) in the design of its dose-schedule for cancer therapy","volume":"5","author":"Karahoca","year":"2013","journal-title":"Clin. Epigenet."},{"key":"10.1016\/j.biopha.2025.118668_bib43","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41563-021-01057-5","article-title":"Next-generation cancer organoids","volume":"21","author":"LeSavage","year":"2022","journal-title":"Nat. Mater."},{"key":"10.1016\/j.biopha.2025.118668_bib44","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s13046-022-02486-z","article-title":"Harnessing preclinical models for the interrogation of ovarian cancer","volume":"41","author":"Qin","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2025.118668_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107762","article-title":"Patient-derived ovarian cancer organoids mimic clinical response and exhibit heterogeneous Inter- and intrapatient drug responses","volume":"31","author":"de Witte","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.biopha.2025.118668_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13122901","article-title":"Successful patient-derived organoid culture of gynecologic cancers for disease modeling and drug sensitivity testing","volume":"13","author":"Bi","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.biopha.2025.118668_bib47","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1158\/2159-8290.CD-18-0474","article-title":"Prediction of DNA repair inhibitor response in short-term patient-derived ovarian cancer organoids","volume":"8","author":"Hill","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.biopha.2025.118668_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106232","article-title":"Developing patient-derived organoids to predict PARP inhibitor response and explore resistance overcoming strategies in ovarian cancer","volume":"179","author":"Tao","year":"2022","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biopha.2025.118668_bib49","doi-asserted-by":"crossref","first-page":"13208","DOI":"10.3390\/ijms241713208","article-title":"Ascites-Derived organoids to depict platinum resistance in gynaecological serous carcinomas","volume":"24","author":"Arias-Diaz","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118668_bib50","doi-asserted-by":"crossref","first-page":"6602","DOI":"10.1158\/1078-0432.CCR-21-1681","article-title":"Organoids derived from neoadjuvant FOLFIRINOX patients recapitulate therapy resistance in pancreatic ductal adenocarcinoma","volume":"27","author":"Farshadi","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2025.118668_bib51","doi-asserted-by":"crossref","first-page":"8544","DOI":"10.1038\/s41467-024-52694-8","article-title":"Molecular and functional landscape of malignant serous effusions for precision oncology","volume":"15","author":"Wegmann","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2025.118668_bib52","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3892\/or.2014.3208","article-title":"Promoter hypermethylation influences the suppressive role of maternally expressed 3, a long non-coding RNA, in the development of epithelial ovarian cancer","volume":"32","author":"Sheng","year":"2014","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.biopha.2025.118668_bib53","doi-asserted-by":"crossref","first-page":"11843","DOI":"10.3390\/ijms252111843","article-title":"Ten hypermethylated lncRNA genes are specifically involved in the initiation, progression, and lymphatic and peritoneal metastasis of epithelial ovarian cancer","volume":"25","author":"Braga","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118668_bib54","doi-asserted-by":"crossref","DOI":"10.1002\/rmb2.12572","article-title":"Identification of long noncoding RNAs downregulated specifically in ovarian high-grade serous carcinoma","volume":"23","author":"Hayashi-Okada","year":"2024","journal-title":"Reprod. Med. Biol."},{"key":"10.1016\/j.biopha.2025.118668_bib55","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12967-024-04929-x","article-title":"m6A methylation-mediated regulation of LncRNA MEG3 suppresses ovarian cancer progression through miR-885-5p and the VASH1 pathway","volume":"22","author":"Li","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.biopha.2025.118668_bib56","article-title":"MEG3 sponges miRNA-376a and YBX1 to regulate angiogenesis in ovarian cancer endothelial cells","volume":"9","author":"Li","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.biopha.2025.118668_bib57","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s12935-020-01259-y","article-title":"LncRNA MEG3 suppressed the progression of ovarian cancer via sponging miR-30e-3p and regulating LAMA4 expression","volume":"20","author":"Liu","year":"2020","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.biopha.2025.118668_bib58","doi-asserted-by":"crossref","first-page":"17709","DOI":"10.1002\/jcb.29037","article-title":"lncRNA MEG3 modified epithelial-mesenchymal transition of ovarian cancer cells by sponging miR-219a-5p and regulating EGFR","volume":"120","author":"Wang","year":"2019","journal-title":"J. Cell Biochem."},{"key":"10.1016\/j.biopha.2025.118668_bib59","doi-asserted-by":"crossref","first-page":"31714","DOI":"10.18632\/oncotarget.15955","article-title":"Upregulation of the lncRNA Meg3 induces autophagy to inhibit tumorigenesis and progression of epithelial ovarian carcinoma by regulating activity of ATG3","volume":"8","author":"Xiu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2025.118668_bib60","doi-asserted-by":"crossref","first-page":"R45","DOI":"10.1530\/JME-12-0008","article-title":"MEG3 noncoding RNA: a tumor suppressor","volume":"48","author":"Zhou","year":"2012","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.biopha.2025.118668_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109129","article-title":"Maternally expressed gene 3 (MEG3): a tumor suppressor long non coding RNA","volume":"118","author":"Ghafouri-Fard","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2025.118668_bib62","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/jb\/mvz097","article-title":"LncRNA MEG3 inhibits the progression of prostate cancer by facilitating H3K27 trimethylation of EN2 through binding to EZH2","volume":"167","author":"Zhou","year":"2020","journal-title":"J. Biochem."},{"key":"10.1016\/j.biopha.2025.118668_bib63","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00439-023-02635-0","article-title":"The pivotal role of long non-coding RNAs as potential biomarkers and modulators of chemoresistance in ovarian cancer (OC)","volume":"143","author":"Malgundkar","year":"2024","journal-title":"Hum. Genet."},{"key":"10.1016\/j.biopha.2025.118668_bib64","doi-asserted-by":"crossref","first-page":"538","DOI":"10.4149\/neo_2022_210726N1046","article-title":"Tumor suppressive lncRNA MEG3 binds to EZH2 and enhances CXCL3 methylation in gallbladder cancer","volume":"69","author":"Li","year":"2022","journal-title":"Neoplasma"},{"key":"10.1016\/j.biopha.2025.118668_bib65","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nature09784","article-title":"The polycomb complex PRC2 and its mark in life","volume":"469","author":"Margueron","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2025.118668_bib66","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3390\/genes10020172","article-title":"The roles of human DNA methyltransferases and their isoforms in shaping the epigenome","volume":"10","author":"Gujar","year":"2019","journal-title":"Genes"},{"key":"10.1016\/j.biopha.2025.118668_bib67","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00280-017-3238-4","article-title":"Curcumin suppresses cisplatin resistance development partly via modulating extracellular vesicle-mediated transfer of MEG3 and miR-214 in ovarian cancer","volume":"79","author":"Zhang","year":"2017","journal-title":"Cancer Chemother. Pharm."},{"key":"10.1016\/j.biopha.2025.118668_bib68","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13148-021-01069-7","article-title":"Advances in epigenetic therapeutics with focus on solid tumors","volume":"13","author":"Jin","year":"2021","journal-title":"Clin. Epigenet."},{"key":"10.1016\/j.biopha.2025.118668_bib69","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13148-021-01045-1","article-title":"Finding an easy way to harmonize: a review of advances in clinical research and combination strategies of EZH2 inhibitors","volume":"13","author":"Li","year":"2021","journal-title":"Clin. Epigenet."},{"key":"10.1016\/j.biopha.2025.118668_bib70","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1158\/1078-0432.CCR-19-1638","article-title":"A randomized phase II trial of epigenetic priming with guadecitabine and carboplatin in Platinum-resistant, recurrent ovarian cancer","volume":"26","author":"Oza","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2025.118668_bib71","doi-asserted-by":"crossref","DOI":"10.1172\/JCI158800","article-title":"Epigenetic priming enhances antitumor immunity in platinum-resistant ovarian cancer","volume":"132","author":"Chen","year":"2022","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.biopha.2025.118668_bib72","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1158\/1535-7163.MCT-17-0437","article-title":"Histone methyltransferase EZH2: a therapeutic target for ovarian cancer","volume":"17","author":"Jones","year":"2018","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.biopha.2025.118668_bib73","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12943-023-01786-y","article-title":"EZH2 mediated metabolic rewiring promotes tumor growth independently of histone methyltransferase activity in ovarian cancer","volume":"22","author":"Chen","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biopha.2025.118668_bib74","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-023-02683-4","article-title":"Precision medicine applied to metastatic colorectal cancer using tumor-derived organoids and in-vitro sensitivity testing: a phase 2, single-center, open-label, and non-comparative study","volume":"42","author":"Jensen","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2025.118668_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2021.100103","article-title":"Prospective experimental treatment of colorectal cancer patients based on organoid drug responses","volume":"6","author":"Ooft","year":"2021","journal-title":"ESMO Open"},{"key":"10.1016\/j.biopha.2025.118668_bib76","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2147\/IJWH.S405010","article-title":"Effective treatment for recurrent ovarian cancer guided by drug sensitivity from Ascites-Derived organoid: a case report","volume":"15","author":"Chen","year":"2023","journal-title":"Int. J. Women\u2019s. Health"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225008625?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225008625?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T23:23:04Z","timestamp":1778541784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225008625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":76,"alternative-id":["S0753332225008625"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118668","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transcriptomic profiling of organoids derived from malignant effusions uncovers lncRNA MEG3 and target genes potentially involved in platinum resistance in serous ovarian carcinoma","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118668","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118668"}}